Canaccord downgraded Quipt Home Medical (QIPT) to Hold from Buy with a price target of $1.70, down from $4.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QIPT:
- Quipt Home Medical: Strategic Initiatives and Financial Resilience Amidst Revenue Challenges
- Quipt Home Medical Reports Q2 2025 Results Amid Revenue Challenges
- Is QIPT a Buy, Before Earnings?
- Quipt Home Medical to Release Q2 2025 Financial Results
- Strategic Growth and Expansion: Quipt Home Medical’s Path to Future Success